Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Lowenstein represented ACA Group in the transaction. ACA Group (ACA), the leading provider of governance, risk, and compliance (GRC) solutions to clients in the financial services...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Hildred Capital in the transaction. Hildred Capital raised $750 million for its continuation fund to extend its ownership of two of its portfolio companies, Hyland’s...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Traub Capital Partners in the transaction. Traub Capital Partners, a strategic private equity firm specializing in building value in consumer companies using its...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz advised Entegris, while Lowenstein Sandler advised Infineum on the deal. Infineum and Entegris, Inc. (NASDAQ: ENTG) have entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Wynnchurch Capital in the transaction. Wynnchurch Capital, L.P. (“Wynnchurch”), a leading middle market private equity firm, executed its investment in Premier Franchise Management...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Wynnchurch Capital in the transaction. Wynnchurch Capital, L.P., a leading middle market private equity firm, executed its acquisition of Mattress Warehouse, LLC, an independent...
You must be a Standard 1 Year member to access this content.
Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...
You must be a Standard 1 Year member to access this content.
Lowenstein, Beccar Varela, and Mattos Filho, Veiga Filho, Marrey Jr. E Quiroga advised Indorama Ventures on the deal. Skadden, Stocche Forbes, BMA – Barbosa, Müssnich, Aragão...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Indorama Ventures in the transaction. Indorama Ventures (BKK: IVL), a global chemicals producer, completed its acquisition of CarbonLite Holdings’ facility in Texas as part of...
You must be a Standard 1 Year member to access this content.
